These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20878593)

  • 41. Developing vaccines against pandemic influenza.
    Wood JM
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Animal models for the preclinical evaluation of candidate influenza vaccines.
    Bodewes R; Rimmelzwaan GF; Osterhaus AD
    Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modelling the strategies for age specific vaccination scheduling during influenza pandemic outbreaks.
    Knipl DH; Röst G
    Math Biosci Eng; 2011 Jan; 8(1):123-39. PubMed ID: 21361404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of vaccination strategies during pandemic outbreaks.
    Bowman CS; Arino J; Moghadas SM
    Math Biosci Eng; 2011 Jan; 8(1):113-22. PubMed ID: 21361403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza: options to improve pandemic preparation.
    Rappuoli R; Dormitzer PR
    Science; 2012 Jun; 336(6088):1531-3. PubMed ID: 22723412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination against influenza: role and limitations in pandemic intervention plans.
    Rebmann T; Zelicoff A
    Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccines for pandemic influenza.
    Luke CJ; Subbarao K
    Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
    Mei L; Song P; Tang Q; Shan K; Tobe RG; Selotlegeng L; Ali AH; Cheng Y; Xu L
    Biosci Trends; 2013 Apr; 7(2):64-76. PubMed ID: 23612075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).
    Poland GA
    Vaccine; 2011 Jan; 29(4):613-4. PubMed ID: 21193121
    [No Abstract]   [Full Text] [Related]  

  • 52. A note on the use of influenza vaccination strategies when supply is limited.
    Lee S; Morales R; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Issues in vaccination against influenza A in Spain].
    Bayas Rodríguez JM; García-Basteiro AL; Mena Pinilla G
    Arch Bronconeumol; 2010 Mar; 46 Suppl 2():32-8. PubMed ID: 20353857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How did the 2008-2009 seasonal influenza vaccine affect the pandemic?
    Glezen WP
    Clin Infect Dis; 2010 Dec; 51(12):1380-2. PubMed ID: 21067354
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccines against epidemic and pandemic influenza.
    Hoelscher M; Gangappa S; Zhong W; Jayashankar L; Sambhara S
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1139-57. PubMed ID: 18817518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity of novel consensus-based DNA vaccines against avian influenza.
    Laddy DJ; Yan J; Corbitt N; Kobinger GP; Weiner DB
    Vaccine; 2007 Apr; 25(16):2984-2989. PubMed ID: 17306909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism.
    Yin JK; Wang H; Skinner SR; Salkeld G; Booy R
    Aust N Z J Public Health; 2011 Aug; 35(4):393-4. PubMed ID: 21806738
    [No Abstract]   [Full Text] [Related]  

  • 59. Pre-pandemic and pandemic influenza vaccines.
    Rockman S; Brown L
    Hum Vaccin; 2010 Oct; 6(10):792-801. PubMed ID: 20935469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Confronting potential influenza A (H5N1) pandemic with better vaccines.
    Haque A; Hober D; Kasper LH
    Emerg Infect Dis; 2007 Oct; 13(10):1512-8. PubMed ID: 18258000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.